You have 9 free searches left this month | for more free features.

Arzerra

Showing 26 - 50 of 53

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • Blinatumomab
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2021

Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

Recruiting
  • Relapsing Multiple Sclerosis
  • +2 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • Best Available Therapy (BAT)
  • Palo Alto, California
  • +20 more
Jan 25, 2023

Chronic Lymphocytic Leukemia, B-Cell Non-Hodgkin's Lymphoma Trial in Philadelphia (Bendamustine, Pentostatin, Ofatumumab)

Terminated
  • Chronic Lymphocytic Leukemia
  • B-Cell Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
May 23, 2018

CLL Trial in La Jolla (Ofatumumab/HDMP)

Completed
  • CLL
  • La Jolla, California
  • +1 more
Apr 9, 2018

Leukemia, Precursor-B Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Cytarabine, Daunorubicin,

Terminated
  • Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 9, 2018

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,

Completed
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2018

Richter's Syndrome Trial in United Kingdom (Ofatumumab)

Completed
  • Richter's Syndrome
  • Birmingham, United Kingdom
  • +8 more
Apr 23, 2018

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)

Terminated
  • Chronic Lymphocytic Leukemia
  • Duarte, California
  • +79 more
Aug 5, 2019

Leukaemia, Lymphocytic, Chronic Trial in Australia, New Zealand, United States (Ofatumumab)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • Ofatumumab
  • La Jolla, California
  • +3 more
Nov 8, 2017

Non-Hodgkin's Lymphoma Trial in Worldwide (Ofatumumab, Rituximab)

Terminated
  • Non-Hodgkin's Lymphoma
  • Ofatumumab
  • Rituximab
  • Anchorage, Alaska
  • +154 more
Apr 16, 2018

Chronic Lymphocytic Leukemia Trial in United States (Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Denver, Colorado
  • +5 more
May 3, 2017

Chronic Lymphocytic Leukemia (CLL) Trial (Dinaciclib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Feb 17, 2017

Leukaemia Trial in Worldwide (Ofatumumab, Physicians' Choice)

Completed
  • Leukaemia
  • Graz, Austria
  • +79 more
Oct 9, 2018

Chronic Lymphocytic Leukemia Trial in Italy (Pentostatin, Cyclophosphamide, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Monza, MB, Italy
  • +11 more
Dec 27, 2016

Chronic Lymphatic Leukemia Trial in Germany (Ofatumumab)

Completed
  • Chronic Lymphatic Leukemia
  • Heidelberg, Baden-Württemberg, Germany
  • +10 more
Sep 16, 2016

Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic Trial in Worldwide (Ofatumumab, Bendamustine)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Leukaemia, Lymphocytic, Chronic
  • Tuscon, Arizona
  • +32 more
Nov 22, 2016

Waldenström Macroglobulinemia Trial in Buffalo, New York (biological, drug, other)

Terminated
  • Waldenström Macroglobulinemia
  • ofatumumab
  • +2 more
  • Buffalo, New York
  • +1 more
May 3, 2016

Diffuse Large B-cell Lymphoma Trial in Singapore (O-ICE (ofatumumab, Ifosfamide, Carboplatin, Etoposide))

Completed
  • Diffuse Large B-cell Lymphoma
  • O-ICE (ofatumumab, Ifosfamide, Carboplatin, Etoposide)
  • Singapore, Singapore
    National Cancer Centre
Mar 21, 2016

Stage III Melanoma, Stage IV Melanoma Trial in Vienna (Ofatumumab, Ofatumumab plus Dacarbazine)

Completed
  • Stage III Melanoma
  • Stage IV Melanoma
  • Ofatumumab
  • Ofatumumab plus Dacarbazine
  • Vienna, Austria
  • +1 more
Oct 4, 2015

Hodgkin Disease Trial in Spain (Ofatumumab)

Completed
  • Hodgkin Disease
  • Badalona, Barcelona, Spain
  • +13 more
Feb 23, 2016

Chronic Lymphocytic Leukemia Trial in Charleston, Greenville (Ofatumumab, Lenalidomide)

Completed
  • Chronic Lymphocytic Leukemia
  • Charleston, South Carolina
  • +1 more
Nov 2, 2015

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone Trial (Ofatumumab)

Withdrawn
  • Lymphoma, Non-Hodgkin
  • +4 more
  • (no location specified)
Oct 8, 2015

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocyctic Leukemia Trial in Columbus (PCI-32765,

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    The Ohio State University
May 28, 2015

Phase IV Observational Study in Chronic Lymphocytic Leukemia

Completed
  • Leukaemia, Lymphocytic, Chronic
  • Arzerra
  • (no location specified)
Jul 3, 2014